Richard Garden, MD
Urology · Westwood, NJNPI 1689642985
Payments from drug & device makers
Across 20 payments — averaging $171.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avyxa Pharma, LLC$3K
- Pfizer$44
- Blueprint Medicines Corporation$20
- Boston Scientific$19
- Olympus America Inc.$17
- Takeda Pharmaceuticals U.S.A., Inc.$17
- plus $106 from 7 others
What the payments were for
- Speaking & faculty fees$2,00058%
- Travel & lodging$84725%
- Food & beverage$56116%
- Education$291%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avyxa Pharma, LLC | 6 | $3,216 |
| Pfizer | 3 | $44 |
| Blueprint Medicines Corporation | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Olympus America Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Amgen | 1 | $16 |
| Neotract Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Novo Nordisk | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$3,438 in reported general payments places this provider in the 60th percentile of 401 urology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 90 | $94,531 |
| OrgovyxRelugolix | 12 | $32,368 |
| GemtesaVibegron | 18 | $23,592 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 740 | $19,570 |
| Mirabegron ErMirabegron | 15 | $13,224 |
| Tamsulosin Hcl | 413 | $9,452 |
| Finasteride | 457 | $6,893 |
| Silodosin | 20 | $2,997 |
| Dutasteride | 44 | $2,210 |
| Potassium Citrate ErPotassium Citrate | 14 | $1,157 |
| Oxybutynin Chloride ErOxybutynin Chloride | 23 | $1,130 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 91 | $516 |
| Solifenacin Succinate | 15 | $509 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 26 | $473 |
| CefuroximeCefuroxime Axetil | 54 | $423 |
Paid to pharmacies, not to this prescriber.
Other urology in Westwood
- Gordon BrownCherry Hill$2.8M
- Nitin YerramHackensack$1.6M
- Michael StifelmanHackensack$1.5M
- Thomas MuellerLinwood$1.2M
- David SussmanLinwood$833K
- Michael IngberDenville$607K
- Ravi MunverHackensack$529K
- Grannum SantBridgewater$487K
- Mutahar AhmedMaywood$464K
- Neil ShermanCranford$404K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.